Document Detail


Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hypothyroidism.
MedLine Citation:
PMID:  20037493     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Paraoxonase-1 (PON-1) may play an important role in atherosclerosis. Atherosclerosis is an inflammatory disease and C-reactive protein is a marker for inflammation. The aim of this study was to determine serum PON-1 activity and high-sensitivity C-reactive protein (hs-CRP) levels and assess carotid intima-media thickness, a marker of early atherosclerotic changes, in patients with subclinical hypothyroidism. MATERIAL/METHODS: hs-CRP concentrations and PON-1 activity with respect to carotid intima-media thickness were evaluated in 38 subclinical hypothyroidism patients (normolipidemic, mean age: 49.79+/-10.04 years) before and after 3 months of stable euthyroidism and compared with those of 19 euthyroid normolipidemic healthy individuals (mean age: 49.95+/-8.12 years). RESULTS: At baseline, the patients with subclinical hypothyroidism had similar levels of PON-1 activity and hs-CRP and a similar lipid profile as the controls; however, the carotid intima-media thickness was greater than in the controls. Levothyroxine treatment had no effect on serum PON-1 activity and hs-CRP level, but it resulted in a significant reduction in carotid intima-media thickness in the subclinical hypothyroidism patients. CONCLUSIONS: PON-1 activity and hs-CRP levels did not significantly differ between subclinical hypothyroid patients and controls. Although levothyroxine treatment might have the potential to reverse the progression of atherosclerosis in subclinical hypothyroid patients, PON-1 activity and hs-CRP levels were not affected by this treatment. The reduction in carotid intima-media thickness was independent of the decrease in serum lipid profile or other variables.
Authors:
Levent Kebapcilar; Abdurrahman Comlekci; Pinar Tuncel; Ahmet Solak; Mustafa Secil; Omur Gencel; Mustafa Sahin; Ismail Sari; Sena Yesil
Related Documents :
10445543 - Clinical relevance of serum interleukin-6 in crohn's disease: single point measurements...
21352813 - Potential risk modifications of gstt1, gstm1 and gstp1 (glutathione-s-transferases) var...
6740353 - Michigan alcoholism screening test to diagnose early alcoholism in a general practice.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Medical science monitor : international medical journal of experimental and clinical research     Volume:  16     ISSN:  1643-3750     ISO Abbreviation:  Med. Sci. Monit.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-28     Completed Date:  2010-03-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9609063     Medline TA:  Med Sci Monit     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  CR41-7     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Dokuz Eylul University, Izmir, Turkey. leventkebapcilar@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aryldialkylphosphatase / blood*
Blood Chemical Analysis
Body Mass Index
Body Weights and Measures
C-Reactive Protein / metabolism*
Carotid Arteries / ultrasonography
Hormone Replacement Therapy / methods*
Humans
Hypothyroidism / blood,  drug therapy*,  enzymology,  pathology
Middle Aged
Statistics, Nonparametric
Thyroxine*
Tunica Intima / pathology*
Chemical
Reg. No./Substance:
7488-70-2/Thyroxine; 9007-41-4/C-Reactive Protein; EC 3.1.8.1/Aryldialkylphosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Short term health impact of a yoga and diet change program on obesity.
Next Document:  Effects of mild-stream bathing on recovery from mental fatigue.